Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial VICCPED1258

Title

Mutations in DICER1 and Related MicroRNA Processing Genes in Dysplasias, Dysontogenic Diseases, Tumors and Other Conditions

Principal Investigator(s)

Adam Esbenshade

Details

  • Protocol No. VICCPED1258
  • Open Date: 09/06/2012
  • Staging: N/A
  • Age Group: Both Child and Adult
  • Scope: International
  • Objective: The general hypothesis we plan to test is that germ-line and somatic mutations in DICER1 are associated with a greater range of benign and malignant conditions than is currently ascribed to dysfunction of DICER1.
  • Disease Sites: Pediatric Solid Tumors
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • Secondary Protocol No: Not Specified

Description

None Provided.

Eligibility

Not provided. Please call for more information.